Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Catheter-directed Thrombolysis Market Outlook (2023 to 2033)

[324 Pages Report] The global catheter-directed thrombolysis market is valued at US$ 454.8 million in 2023. The market is likely to grow at a CAGR of 5.9% and is anticipated to be valued at US$ 808 million by 2033.

The demand for catheter-directed thrombolysis is anticipated to increase as the treatment makes use of processes that remove the clot be it based on thrombosis or embolization, the low time duration of treatment, and many other factors. This process is one of the most important preferred methods to treat stroke and related health issues.

Report Attributes Details
Catheter-Directed Thrombolysis Market Value (2023) US$ 454.8 million
Catheter-Directed Thrombolysis Market Anticipated Value (2033) US$ 808 million
Catheter-Directed Thrombolysis Market Projected Growth Rate (2023 to 2033) 5.9%

Even if we compare the historical CAGR with the anticipated CAGR of the forecast period, there is a positive indication for the market. The historical CAGR of the catheter-directed thrombolysis industry from 2018 to 2022 was 4.9%, while the anticipated CAGR is 5.9%. The good thing is that the market is progressing because of the number of benefits catheter-directed thrombolytic therapy offers.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Prominent Drivers and Restraints in the Catheter-directed Thrombolysis Market

The seamlessness that this process offers is almost unmatchable. The entire process is done under the purview of X-ray imaging to get the correct site of the clot. Moreover, the technique is used for several treatments, which include thrombosis in the vascular bed, deep vein thrombosis, and thrombosis of dialysis fistulate. This is expected to increase the adoption of catheter-directed thrombolysis and makes the entire process an essential form of stroke medication.

Additionally, on comparing with the traditional heart surgery process, the process is extremely safe, and the duration for which the patient is admitted to the hospital is less. Besides that, based on the stats provided by WHO, it was found that around 17.9 million people died from heart disease in 2019, accounting for 32% of global deaths. This is something that has captured the attention of investors in the catheter-directed thrombolysis industry, as these are mainly used for treating heart diseases.

Furthermore, the availability of emergency medical services and favorable health insurance coverage will also fuel the catheter-directed thrombolysis industry. All these are anticipated to have a positive impact on the catheter-directed thrombolysis market trends and forecasts. However, the application of an IV line to administer anesthesia might lead to certain injuries to the skin. This can be a cause of concern for the catheter-directed thrombolysis industry.

Fluoroscopy: The “Big Cheese” of Catheter-directed Thrombolysis Market

The amazing ability to keep real-time track of the movements inside the body part has been made possible because of fluoroscopy. The application of fluoroscopy has been perceived as a life-saving surgical treatment. Apart from showing the real-time view, this method also helps medical practitioners to place the catheters inside the body with precision.

Moreover, fluoroscopy is used in a wide variety of examinations like Barium x-rays, placement of stents, and orthopedic surgery to carry out a variety of treatments which include viewing the gastrointestinal tract, visualizing blood vessels, guiding joint replacements, etc. Thus, from the above, it can be inferred that the usage of fluoroscopy is likely to increase the scope of the catheter-directed thrombolysis industry.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Catheter-directed Thrombolysis Market: Best Way Forward

Attributes Details
Replacing X-rays with Ultrasounds Continuous exposure to X-rays can lead to health complications. Instead of this, the manufacturers can look for ways to replace X-rays with ultrasound, as these can be applied to any kind of patient, even pregnant women. Moreover, there are no side effects associated with the usage of ultrasounds, and the image quality provided by the usage of ultrasounds is also good. Thus, the replacement of X-rays with ultrasound might very well improve the catheter-directed thrombolysis industry outlook.
Replacing the IV method with other methods Instead of applying an invasive technique to administer anesthesia, the administration can be done through other methods, like administering it in the form of a gas, topical liquid, or any injection. The problem associated with intravenous medication is that it can lead to infection and damage the site of veins and may also lead to air embolism. However, replacing the IV line with anesthesia through gas, topical liquid, or injection is expected to avoid any instances of developing a skin infection or any other kind of complication as these are not pierced into the skin, thereby making the process fully non-invasive, except for the case of injection. The application of any one of these methods can be a positive step for the catheter-directed thrombolysis market.

Regional Analysis

Attributes Details
North America North America is expected to dominate the catheter-directed thrombolysis industry share due to easy access to advanced healthcare facilities. According to Future Market Insights, the North American catheter-directed thrombolysis market has a market share of 53.4% and is expected to grow at a rapid pace during the forecast period. Moreover, the region is meant for rapid technological advances. According to World Health Organization (WHO), approximately 900,000 people were diagnosed with pulmonary embolism and deep vein thrombosis in the USA. in 2015. Among all end users, the hospital segment dominates the market for catheter-directed thrombolysis over the forecast period. The majority of cases of pulmonary embolism and deep vein thrombosis are treated in hospitals.
Europe Europe is considered to be the 2nd largest market for catheter-directed thrombolysis owing to the presence of a robust reimbursement scenario and improved regulatory framework. According to Future Market Insights, the region has a market share of 24.1% and is expected to grow significantly during the forecast period. Catheter-directed thrombolysis (CDT) with assisted mechanical thrombolysis in the region is considered the standard form of treatment. Deep vein thrombosis (DVT) is the third most common cardiovascular pathology after coronary artery disease and stroke in the region. Due to the growing geriatric population and risk factors that include oral contraceptives, the demand for catheter-directed thrombolysis is expected to increase during the forecast period in Europe.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Start-up Ecosystem

Start-ups are developing new products with their unique ideas to solve several problems, especially in medical fields for patients. Start-ups in the catheter-directed thrombolysis industry are making new devices that help to prevent cardiovascular disease. Some of the start-ups are:

Corvus Medical:

Corveus Medical is a US-based start-up company that has developed a new device to prevent heart failure in recent years. The innovative device developed by a company named “neuromodulation device” helps to access heart tissues uniquely and safely.

Moray Medical:

Moray Medical is another US-based start-up that improves leaky heart valves by providing microfluidic robotic methods. The start-up treats its patients safely with cost-effective therapies.

Competitive Landscape

The market is consolidated by the prominent vendors present all around the region in recent years. They are using several marketing tactics to acquire lion’s share and are anticipated to grow the catheter-directed thrombolysis market share during the forecast period.

Some of the marketing methodologies adopted by key players are partnerships, acquisitions, mergers, product launches, and collaborations among others. Global players such as Angio Dynamics, Inc. and Boston Scientific Corporation account for a considerable market size. Several regional-level players are also operating across key growth regions.

Recent Developments in the Catheter-Directed Thrombolysis Market:

  • AngioDyamics Inc. is a prominent player when it comes to offering catheter-directed thrombolysis devices. Its Uni-FuseTM Infusion Catheter offers a highly effective treatment for clots. The catheter’s sturdier construction allows for inserting stronger catheters with enhanced usability
  • In September 2021, Boston Scientific Corporation purchased an 84% stake in Devoro Medical, further expanding its footprint in the blood clot removal platform of its existing thrombectomy portfolio. The deal saw Boston Scientific put down about US$ 269 Million upfront.
  • vascular SLU received the CE Mark approval for its BX-covered stent iCover in May 2021. Balloon-expanding (BX) covered stents are commonly used for treating arteriosclerotic lesions in renal and iliac arteries and for the treatment of aneurisms and ruptures. iCover can adapt to the most tortuous vessels due to its high flexibility and outstanding post-expansion capacity. It also offers excellent visibility.

Some of the key participants present in the market include

  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • iVascular SLU
  • Straub Medical AG

Report Scope

Report Attributes Details
Growth Rate CAGR of 5.9% from 2023 to 2033
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Delivery Mode
  • Indication
  • End User
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Argentina
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa
Key Companies Profiled
  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • iVascular SLU
  • Straub Medical AG
Customization Available Upon Request

Key Segments

By Delivery Mode:

  • Direct Delivery to Blood Clot Catheter-directed Thrombolysis
  • Catheter-directed Thrombolysis by Positioning Medical Device at Clot Site

By Indication:

  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Strokes
  • Other Indications

By End User:

  • Hospitals
  • Surgical Centers
  • Radiology Clinics

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa
  • Europe

Frequently Asked Questions

What is the current market value?

The market is valued at US$ 454.8 million by 2023.

What is projected value of the market by 2033?

The market is predicted to reach a size of US$ 808 million by 2033.

Which country to account for significant share in market?

United States to hold sizeable share in the market.

At what CAGR is the industry projected to grow?

A CAGR of 5.9% is predicted for the market by 2033.

How is the historical performance of the market?

From 2018 to 2022, the market registered a CAGR of 4.9%.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Delivery Mode

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Delivery Mode, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Delivery Mode, 2023 to 2033

        5.3.1. Direct Delivery to Blood Clot Catheter-directed Thrombolysis

        5.3.2. by Positioning Medical Device at Clot Site

    5.4. Y-o-Y Growth Trend Analysis By Delivery Mode, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Delivery Mode, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033

        6.3.1. Pulmonary Embolism (PE)

        6.3.2. Deep Vein Thrombosis (DVT)

        6.3.3. Strokes

        6.3.4. Other Indications

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Surgical Centers

        7.3.3. Radiology Clinics

    7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA.

            9.2.1.2. Canada

        9.2.2. By Delivery Mode

        9.2.3. By Indication

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Delivery Mode

        9.3.3. By Indication

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Delivery Mode

        10.2.3. By Indication

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Delivery Mode

        10.3.3. By Indication

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Delivery Mode

        11.2.3. By Indication

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Delivery Mode

        11.3.3. By Indication

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Delivery Mode

        12.2.3. By Indication

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Delivery Mode

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Delivery Mode

        13.2.3. By Indication

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Delivery Mode

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Delivery Mode

        14.2.3. By Indication

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Delivery Mode

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Delivery Mode

        15.2.3. By Indication

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Delivery Mode

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Delivery Mode

            16.1.2.2. By Indication

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Delivery Mode

            16.2.2.2. By Indication

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Delivery Mode

            16.3.2.2. By Indication

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Delivery Mode

            16.4.2.2. By Indication

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Delivery Mode

            16.5.2.2. By Indication

            16.5.2.3. By End User

    16.6. United Kingdom.

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Delivery Mode

            16.6.2.2. By Indication

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Delivery Mode

            16.7.2.2. By Indication

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Delivery Mode

            16.8.2.2. By Indication

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Delivery Mode

            16.9.2.2. By Indication

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Delivery Mode

            16.10.2.2. By Indication

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Delivery Mode

            16.11.2.2. By Indication

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Delivery Mode

            16.12.2.2. By Indication

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Delivery Mode

            16.13.2.2. By Indication

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Delivery Mode

            16.14.2.2. By Indication

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Delivery Mode

            16.15.2.2. By Indication

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Delivery Mode

            16.16.2.2. By Indication

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Delivery Mode

            16.17.2.2. By Indication

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Delivery Mode

            16.18.2.2. By Indication

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Delivery Mode

            16.19.2.2. By Indication

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Delivery Mode

            16.20.2.2. By Indication

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Delivery Mode

            16.21.2.2. By Indication

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Delivery Mode

            16.22.2.2. By Indication

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Delivery Mode

            16.23.2.2. By Indication

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Delivery Mode

        17.3.3. By Indication

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. AngioDynamics Inc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Boston Scientific Corporation

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. iVascular SLU

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Straub Medical AG

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Thrombolex Inc.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Teleflex Incorporated

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Straub Medical AG

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Penumbra, Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Medtronic Plc

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Inari Medical, Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Balloon Catheter Market

Published : January 2023

Healthcare

Stent Graft Balloon Catheter Market

Published : November 2022

Explore Healthcare Insights

View Reports

Catheter-Directed Thrombolysis Market